DNA sequencing of CREBBP demonstrates mutations in 56% of patients with 
Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS

Bartsch, O.; Schmidt, S.; Richter, M.; Morlot, S.; Seemanová, E.; Wiebe, G.; Rasi, S.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS

MPS-Authors

/persons/resource/persons219789

Wiebe, G.
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Bartsch, O., Schmidt, S., Richter, M., Morlot, S., Seemanová, E., Wiebe, G., et al. (2005). DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Human Genetics, 117(5), 485-493.

Cite as: https://hdl.handle.net/21.11116/0000-0001-1124-3

Abstract

There is no abstract available